Omeros reported $313.9M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acelrx Pharmaceuticals ACRX:US $ 11.85M 1.95M
Adma Biologics ADMA:US $ 138.42M 43.56M
Aerie Pharmaceuticals AERI:US $ 311.68M 77.15M
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Cytokinetics CYTK:US $ 197.98M 55.14M
Dynavax Technologies DVAX:US $ 220.76M 0.27M
Gilead Sciences GILD:US $ 26208M 487M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Insmed INSM:US $ 806.79M 225.49M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
Knight Therapeutics Inc GUD:CN C$ 46.79M 5.83M
Mirati Therapeutics MRTX:US $ 0M 0M
Omeros OMER:US $ 313.9M 517K
Regulus Therapeutics RGLS:US $ 4.41M 0.26M
Sangamo Biosciences SGMO:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 0 0